East Main Vision Clinic offers iLight low-level light therapy in Puyallup, WA, for patients with chronic dry eye conditions and certain stages of dry age-related macular degeneration. Also known as photobiomodulation, this non-invasive treatment uses red, blue, yellow, and infrared light therapy to support cellular function, reduce inflammation, and promote healthier eye tissue.

What Is LLLT for Dry Eye?

Low-level light therapy uses red light to address inflammation and poor meibomian gland function. These glands produce the protective oil layer that keeps tears from evaporating too quickly. When the glands become blocked or inflamed, patients may experience burning, redness, tearing, blurry vision, or difficulty wearing contact lenses.

We may recommend LLLT in Puyallup for patients with:

• Meibomian gland dysfunction

• Evaporative dry eye

• Ocular rosacea

• Blepharitis

• Contact lens intolerance

• Refractory dry eye that has not improved with traditional care

How Low-Level Light Therapy Works

LLLT delivers controlled light energy to the tissue around the eyes. This process is designed to stimulate mitochondrial activity and increase adenosine triphosphate, commonly called ATP. ATP provides the energy cells need to function, repair tissue, and regulate inflammation.

By supporting cellular metabolism, low-level light therapy can reduce eyelid inflammation and improve meibomian gland performance. Healthier glands can release better-quality oils into the tear film, helping tears remain stable across the surface of the eyes.

Benefits of LLLT for Dry Eye

Low-level light therapy can improve tear film stability and relieve symptoms by supporting healthier meibomian gland function. Benefits may include:

• Improved meibum quality

• Easier meibomian gland expression

• Increased tear break-up time

• Greater tear film lipid layer thickness

• Reduced eyelid inflammation

• Improved overall eye comfort

• Better contact lens tolerance

• Reduced burning, excessive tearing, and fluctuating vision
  
  

Low-Level Light Therapy for Dry AMD

Photobiomodulation can also be used to support retinal cells affected by dry age-related macular degeneration. Dry AMD is associated with oxidative stress, chronic inflammation, mitochondrial dysfunction, retinal pigment epithelium dysfunction, and gradual photoreceptor loss.

The delivery System uses specific wavelengths of yellow, red, and near-infrared light to improve mitochondrial function and reduce oxidative stress within retinal cells. This is FDA-authorized to improve visual acuity in certain patients with dry AMD.

This treatment is non-invasive, needle-free, painless, and requires no recovery time. For eligible patients, it may improve visual function and support efforts to slow changes associated with geographic atrophy. A comprehensive retinal evaluation is required to determine whether it is appropriate based on the type and stage of AMD.

What to Expect During Treatment

iLight low-level light therapy is a comfortable, non-invasive treatment performed in our Puyallup office. Patients typically feel gentle warmth but should not experience pain.

There are no needles, incisions, or recovery time. Patients can return to their normal activities immediately after treatment. The number and frequency of sessions will depend on whether iLight is being used for dry eye or dry AMD, along with the severity of the condition and the patient’s individual treatment plan.

Start Your Personalized LLLT Treatment Plan